Gapping up
In reaction to earnings/guidance:
- OTIS +2.2%, KO +1.4%
Other news:
- ERYP +53.3% (ells U.S. manufacturing facility and enters long-term supply agreement with Catalent (CTLT))
- NKTX +48.5% (announces positive preliminary dose finding data for two lead engineered natural killer cell programs)
- ARDX +42.7% (FDA to convene Advisory Committee for XPHOZAH (tenapanor))
- CANG +22.9% (announced the declaration of a special cash dividend and a new share repurchase program)
- TWTR +5.4% (on track to reach deal with Elon Musk)
- OTIS +2.2% (increases its quarterly dividend 20.8% to $0.29/share)
Analyst comments:
- MRVL +0.4% (upgraded to Outperform from Mkt Perform at Raymond James)
- AMD +0.2% (upgraded to Strong Buy from Outperform at Raymond James)
